SAN FRANCISCO -Nov. 14, 2018- Viz.ai, Inc., an applied artificial intelligence company, has been designated as a compatible vendor for the American Heart Association/American Stroke Association Get With The Guidelines registry, the premier program for assisting hospitals in measuring and improving cardiovascular disease and stroke care through research-based guidelines.
The Association’s Get With The Guidelines - Stroke program currently supports healthcare professionals in over 2,000 hospitals and is designed to improve stroke care by promoting consistent adherence to the most up-to-date research and scientific publications, clinical tools and resources, quality improvement field staff support, patient education resources, and continuous quality improvement performance feedback reporting. Since the program’s inception in 2003, over 5 million stroke patient records have been recorded into the GWTG database.
As a compatible vendor, Viz.ai aims to improve quality metrics in the stroke workflow by facilitating fast and accurate detection and referral of large vessel occlusion strokes and enabling better collaboration between the stroke teams at comprehensive and referral hospitals.
“The inclusion of Viz.ai as an American Heart Association Get With the Guidelines Compatible Vendor demonstrates the potential role that applied artificial intelligence and workflow software has in providing consistent quality care,” said Raul Nogueira, MD, Professor of Neurology at Emory University and Director of Grady’s Neuroendovascular Service. “Viz LVO serves as a fully automated stroke alert system that identifies suspected LVO patients who may be eligible for life-changing mechanical thrombectomy.”
Viz.ai’s comprehensive suite of deep learning applied artificial intelligence and workflow software automatically detects and directly alerts on-call stroke specialists about suspected large vessel occlusions (LVOs) across their entire stroke network in just minutes. When combined with insights from Viz CTP automated perfusion software and the convenience of Viz VIEW’s mobile viewing and Viz HUB’s HIPAA-compliant messaging software. Viz LVO significantly augments stroke teams’ capability to proactively identify and triage a potential stroke.1 It enables the right decision to be made by the right specialist at the right time.
“The Get With The Guidelines – Stroke program is the foremost program for improving stroke care by promoting consistent adherence to the latest scientific treatment guidelines,” said Chris Mansi, Neurosurgeon and CEO of Viz.ai. “The Get with the Guidelines – Stroke program has demonstrated improvements in stroke care in over 2,000 hospitals. Viz.ai is honored to be a compatible vendor that has demonstrated achieving measurable patient outcome improvements.”
Stroke is a leading cause of permanent disability, death and healthcare costs globally. According to the American Heart Association/American Stroke Association, stroke is the fifth leading cause of death in the U.S. and a leading cause of disability. When a stroke occurs, and the flow of oxygen-rich blood to a portion of the brain is blocked, 2 million brain cells die every minute meaning "Time is Brain."
About Viz.ai, Inc.
Viz.ai is the leader in AI-driven intelligent care coordination. Viz.ai’s mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce time to treatment, improve access to care, and increase the speed of diffusion of medical innovation. Viz.ai’s clinically validated platform leverages advanced deep learning to communicate time-sensitive information to specialists who can more quickly and easily make treatment decisions for the patient. In February 2018, Viz.ai became the first-ever computer-aided triage and notification software. In 2020, CMS granted Viz.ai the first New Technology Add-on Payment (NTAP) for artificial intelligence software for Viz LVO.
Viz.ai is located in San Francisco and Tel Aviv and backed by leading Silicon Valley investors, including Kleiner Perkins, Google Ventures, Greenoaks, CRV, Threshold Ventures,Innovation Endeavors, Susa Ventures, Scale Venture Partners and InsightPartners.
About the American Stroke Association
The American Stroke Association is devoted to saving people from stroke — the No. 2 cause of death in the world and a leading cause of serious disability. We team with millions of volunteers to fund innovative research, fight for stronger public health policies, and provide lifesaving tools and information to prevent and treat stroke. The Dallas-based association was created in 1998 as a division of the American Heart Association. To learn more or to get involved, call 1-888-4STROKE or visit strokeassociation.org. Follow us on Facebook and Twitter.
1 FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm596575.htm